S. Saito et al., Effects of inhaled bronchodilators on pulmonary hemodynamics at rest and during exercise in patients with COPD, CHEST, 115(2), 1999, pp. 376-382
Citations number
37
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Introduction: Inhaled anticholinergic drugs are often recommended for use a
s a first-line therapy for patients with COPD because they provide similar
or more effective bronchodilating actions, as well as fewer side effects. I
t is not known, however, which class of bronchodilators is more advantageou
s for pulmonary hemodynamics, particularly during exercise.
Objectives: To compare the effects of oxitropium and fenoterol on pulmonary
hemodynamics in patients with COPD at rest and during exercise.
Patients: The study participants consisted of 20 consecutive male patients
with stable COPD, a mean (+/- SD) age of 68 +/- 8 years old, and an FEV1/FV
C ratio of 47.5 +/- 10.%, Methods: Eleven patients inhaled two puffs of oxi
tropium, and nine patients inhaled two puffs of fenoterol, Seven members of
each group performed incremental exercise using a cycle ergometer, The hem
odynamic measurements with right heart catheterization were performed by ta
king the average of three consecutive respiratory cycles before and after t
he administration of inhaled bronchodilators at rest and during exercise.
Results: At rest, despite a similar improvement of spirometric data with th
e two drugs, fenoterol, not oxtropium, caused significant increases in hear
t rate and cardiac output, a decrease in pulmonary vascular resistance, and
a deteriorated Pao(2). During exercise, however, both drugs similarly atte
nuated elevations in the mean pulmonary arterial pressure (40 +/-2 to 38 +/
- mm Hg by oxitropium, and 41 +/- to 36 +/- mm Ng by fenoterol), the mean p
ulmonary capillary wedge pressure, and the mean right atrial pressure.
Conclusion: Our findings indicate that both classes of bronchodilators are
equally beneficial in the attenuation of right heart afterload during exerc
ise in patients with COPD.